Quick and easy sterile connections for single-use biopharmaceutical processing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Quick and easy sterile connections for single-use biopharmaceutical processing

AseptiQuik® connectors from CPC make single-use sterile connections faster, easier and safer than ever before.Robust, easy-to-use connector designs enable users to quickly transfer valuable media with more confidence and less risk of operator error. AseptiQuik® connectors provide reliable, sterile connections without the need for clamps, fixtures or tube welding.

The newest addition to CPC’s sterile connection technologies, genderless AseptiQuik® G connectors simplify single-use systems design and process integration. Our innovative design eliminates separate male and female components to substantially reduce complexity and support modular system design. Because the connectors are interchangeable—any single-use G series connector mates with any other G series connector—systems are more flexible and minimize supply chain complexity.

The AseptiQuik family offers the broadest range of single-use sterile connectors in the industry with flow configurations from 3.2mm to 25.4mm (1/8” to 1”). AseptiQuik’s are ideal for applications where reliability and sterility are a must—including single-use bag and tubing assemblies, cell banking systems, bioreactors, mixers, sampling, formulation and filling. See the AseptiQuikvideos.

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here